Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: Market Pathways August-September 2026

The recently-proposed RAPID pathway to align regulatory approval and Medicare coverage is getting a mixed reception from industry and reimbursement experts. Similarly, the jury is still out on new EU-wide Joint Clinical Assessments to streamline European market access. The MDUFA VI draft aims to mostly maintain the status quo; CMS offers a two-year grace period for NTAPs; and we unveil our new and improved Document Depot global policy database.

Read Article